Apontis Pharma AG (APPH) — Cash Flow Quality Index
Apontis Pharma AG (APPH) has a Cash Flow Quality Index of -3.22x as of June 2025. Operating cash flow of €-1.94 Million is below net income of €603.75K, suggesting accrual-heavy earnings not yet converted to cash. Explore Apontis Pharma AG (APPH) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apontis Pharma AG Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for Apontis Pharma AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Apontis Pharma AG.
Annual Cash Flow Quality Index for Apontis Pharma AG (2022–2024)
Year-by-year earnings quality comparison for Apontis Pharma AG.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -3.85x | €-2.90 Million | €753.57K | ▼ -193.9% |
| 2022 | 4.10x | €11.02 Million | €2.69 Million | — |